MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
University of Utah · Huntsman Cancer Institute · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
605
total citations
- FWCI
- 20.18
- Percentile
- 100%
- References
- 57
Citations per year
Authors
29Topics & keywords
Topics
Keywords
- Cancer research
- Suppressor
- Biology
- Chemotherapy
- Lung cancer
- Small Cell Lung Carcinoma
- Aurora kinase
- Neuroendocrine tumors
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- ACAmerican Cancer SocietyAward: RSG-13-300-01-TBG
- BIBoehringer Ingelheim
- DRDamon Runyon Cancer Research FoundationAward: DRR-26-13
- VFV Foundation for Cancer Research
- ELEli Lilly and Company
- RRoche
- SSanofi
- CPCancer Prevention and Research Institute of TexasAward: RP140143
- MSMeso Scale Diagnostics
- MKMerck KGaA
- COClovis Oncology
- DFDeutsche ForschungsgemeinschaftAward: TH1386/3-1
- DDaiichi-Sankyo
- DKDeutsche KrebshilfeAward: 109679
- NINational Institutes of HealthAward: R01CA187457-01
- JAJohnson and Johnson
- NPNovartis Pharma
- EREuropean Regional Development FundAward: LS-1-1-030a